Sale of Reagents closed

Sanquin Health Solutions has officially transferred the Reagents business unit. As of now, Gilde Healthcare is the new shareholder of Sanquin Reagents.

Gilde Healthcare is a Dutch investment company with years of experience in healthcare. Last August, we already reported on the proposed sale.

Gilde Healthcare is the ideal party to further develop Sanquin Reagents, after its successful development and growth within the Sanquin Group, as an international producer of diagnostic tests for professional use in healthcare. The sale proceeds will be invested in, among other things, research and development of medicines and healthcare innovations for patients.

Reagents will remain situated in Amsterdam at Sanquin's Health & Innovation District.